Legal & FDA
Safety
How to Spot Counterfeit GLP-1 Medications: Red Flags
Protect yourself from counterfeit semaglutide and tirzepatide with this comprehensive safety guide.
Last updated: March 30, 2026·15 min read
FDA Warning
The FDA has confirmed the presence of counterfeit Ozempic in the U.S. drug supply chain. Some counterfeits contained insulin instead of semaglutide, posing a life-threatening hypoglycemia risk. Only obtain GLP-1 medications from verified, licensed sources.
The global demand for GLP-1 medications has created a lucrative market for counterfeiters. From fake Ozempic pens to fraudulent online pharmacies, the risks are real and growing. In 2024 alone, the FDA investigated multiple cases of counterfeit semaglutide that had entered the legitimate U.S. supply chain. Here is how to protect yourself.
10 Red Flags for Counterfeit GLP-1 Medications
- No prescription required. Any source selling semaglutide or tirzepatide without a valid prescription from a licensed provider is operating illegally.
- Prices significantly below market. Brand-name Wegovy costs $1,300+/month. If someone offers it for $100-200, it is almost certainly counterfeit or diluted.
- Sold through social media. Instagram, TikTok, Facebook Marketplace, and Telegram groups are primary channels for counterfeit medications.
- Packaging quality issues. Misspelled words, blurry printing, incorrect colors, flimsy packaging, or missing tamper-evident seals.
- Missing or incorrect lot numbers. Every legitimate pen has a traceable lot number that can be verified with the manufacturer.
- Unusual medication appearance. Cloudy, discolored, or particle-containing solution may indicate a counterfeit or degraded product.
- No physical address for the seller. Legitimate pharmacies have verifiable physical locations and contact information.
- Ships from overseas. Medications shipped directly from China, India, or other countries without going through an FDA-registered importer carry high counterfeit risk.
- The pen feels or operates differently. Counterfeit pens may have different click patterns, resistance, or dose selection mechanisms than authentic products.
- No expected effects. If you experience zero appetite suppression or side effects after starting, the product may contain no active ingredient.
How to Verify Your Medication Is Authentic
Verification Checklist
- Purchase from a licensed U.S. pharmacy. Verify state license through your state board of pharmacy website.
- Check the NDC (National Drug Code). Every FDA-approved medication has a unique NDC number. Verify it matches the medication listed in the FDA database.
- Verify lot numbers. Contact Novo Nordisk (1-800-727-6500) or Eli Lilly (1-800-545-5979) to verify lot number authenticity.
- Inspect packaging carefully. Compare to images on the manufacturer's official website. Check for tamper-evident seals, proper labeling, and print quality.
- Visually inspect the medication. Must be clear, colorless, and free of particles.
- For compounded products: Verify pharmacy credentials (503A state license or 503B FDA registration).
What Counterfeit GLP-1 Medications May Contain
FDA testing of seized counterfeit GLP-1 products has found a disturbing range of contents:
- No active ingredient: Simply saline or bacteriostatic water, meaning zero therapeutic effect
- Wrong active ingredient: Insulin instead of semaglutide (causing dangerous hypoglycemia)
- Incorrect dose: Much less or much more than labeled, leading to underdosing or overdosing
- Contaminants: Bacterial contamination, heavy metals, or other chemical impurities
- Non-sterile preparations: Risk of injection site infections, abscesses, or systemic infection
- Degraded peptide: Improperly stored or expired raw material with reduced potency
Where to Safely Purchase GLP-1 Medications
Brand-Name Products
- Retail pharmacies (CVS, Walgreens, Rite Aid, etc.) with a valid prescription
- Specialty pharmacies authorized by the manufacturer
- Hospital and clinic pharmacies
- Manufacturer direct programs (LillyDirect for Zepbound)
Compounded Products
- State-licensed 503A compounding pharmacies with verified credentials
- FDA-registered 503B outsourcing facilities
- Telehealth programs that partner with verified pharmacies
Never Purchase From
- Social media sellers
- Unverified websites without pharmacy credentials
- International sellers shipping directly to consumers
- Peer-to-peer marketplaces (eBay, Craigslist, etc.)
- Any source that does not require a prescription
How to Report Suspected Counterfeits
- FDA MedWatch: 1-800-FDA-1088 or online at fda.gov/medwatch
- FDA Office of Criminal Investigations: tips@fda.hhs.gov
- State board of pharmacy: Report unlicensed sellers
- Manufacturer: Contact Novo Nordisk or Eli Lilly directly
- FTC: Report deceptive advertising at ftc.gov/complaint
Key Takeaways
- Counterfeit GLP-1 medications are a real and growing threat
- Always purchase from licensed U.S. pharmacies with valid prescriptions
- Verify lot numbers, NDC codes, and packaging against manufacturer records
- Be especially wary of social media sellers and unusually low prices
- Counterfeit products can contain dangerous substances or no active ingredient
- Report suspected counterfeits to the FDA and your state board of pharmacy
Medical Disclaimer: This article is for educational purposes only. If you suspect you have used a counterfeit medication, contact your healthcare provider immediately and report it to the FDA.
Verified, Safe GLP-1 Medications
Trimi Health sources exclusively from verified, licensed pharmacies with rigorous quality testing.
Get Started TodayMore on legal & FDA
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).